跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BORTEZOMIB DR REDDYS 2,5 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BORTEZOMIB DR REDDYS 2,5 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
BORTEZOMIB DR REDDYS 2,5 MG/ML SOLUCION INYECTABLE
Reddy Pharma Iberia S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 9, 2024
Approval ID
a226e2ddad1cad75
Company
Reddy Pharma Iberia S.A.
Type
Standard
Approval Details
Approval Id
a226e2ddad1cad75
Drug Cima Aemps Name
BORTEZOMIB DR REDDYS 2,5 MG/ML SOLUCION INYECTABLE
Register Number
89693
Holder Company Name
Reddy Pharma Iberia S.A.
Marketing Company Name
Reddy Pharma Iberia S.A.
Authorization Date
2024-07-09
Dosage Form
SOLUCIÓN INYECTABLE
Dose
2,5 mg/ml
Route Of Administration
VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Reddy Pharma Iberia S.A.
Active Ingredients
BORTEZOMIB
2,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 9, 2024
Approval ID
a226e2ddad1cad75
Type
Standard
Back to CIMA-AEMPS Approvals
